Abstract
Hospices have been implementing various approaches to cope with the increased regulatory scrutiny in the last 3 years, prompted by concern about costs and outcomes. Medicare, through its fiscal intermediaries, has issued increasingly more restrictive local coverage determination (LCD) guidelines for initial and ongoing qualifying criteria. The regulatory focus has been intensified and extended by the 2010 federal health care reform legislation. The article examines how one hospice clinical management team is managing the convergence of the increased regulation and the new federal health care reform requirements.
Get full access to this article
View all access options for this article.
